Tong-Chuan He to Protein-Tyrosine Kinases
This is a "connection" page, showing publications Tong-Chuan He has written about Protein-Tyrosine Kinases.
Connection Strength
1.026
-
Modulation of ß-catenin signaling by the inhibitors of MAP kinase, tyrosine kinase, and PI3-kinase pathways. Int J Med Sci. 2013; 10(13):1888-98.
Score: 0.419
-
Tyrosine kinase inhibitor STI-571: the new wonder drug of cancer therapy. Cancer Biol Ther. 2004 Apr; 3(4):393-4.
Score: 0.215
-
Erythropoietin-induced recruitment of Shc via a receptor phosphotyrosine-independent, Jak2-associated pathway. J Biol Chem. 1995 May 12; 270(19):11055-61.
Score: 0.116
-
The extended box 2 subdomain of erythropoietin receptor is nonessential for Jak2 activation yet critical for efficient mitogenesis in FDC-ER cells. J Biol Chem. 1994 Jul 15; 269(28):18291-4.
Score: 0.109
-
Tyrosine kinase inhibitor STI-571/Gleevec down-regulates the beta-catenin signaling activity. Cancer Lett. 2003 Apr 25; 193(2):161-70.
Score: 0.050
-
The box1 domain of the erythropoietin receptor specifies Janus kinase 2 activation and functions mitogenically within an interleukin 2 beta-receptor chimera. J Biol Chem. 1996 Jul 12; 271(28):16472-6.
Score: 0.031
-
Erythropoietin-dependent inhibition of apoptosis is supported by carboxyl-truncated receptor forms and blocked by dominant-negative forms of Jak2. J Biol Chem. 1995 Jun 16; 270(24):14500-4.
Score: 0.029
-
Dominant negative effects of a carboxy-truncated Jak2 mutant on Epo-induced proliferation and Jak2 activation. Biochem Biophys Res Commun. 1994 Oct 14; 204(1):278-83.
Score: 0.028
-
Inhibition of erythropoietin-induced mitogenesis by a kinase-deficient form of Jak2. J Biol Chem. 1994 Aug 26; 269(34):21411-4.
Score: 0.028